The Cancer Genome Atlas (TCGA) analyzed mutational genetic events and identified three core signaling pathways commonly activated in human GBM: the tumor protein p53 pathway, the receptor tyrosine kinase (RTK)/Ras/phosphoinositide 3-kinase signaling pathway, and the retinoblastoma pathway [33,34]. Here, TP53 is linked to glioblastoma.